Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
Persevere Therapeutics is a clinical-stage oncology company developing misetionamide, a small molecule asset with a novel dual-target mechanism that inhibits cancer cell energy metabolism and proliferation. The company is advancing misetionamide through clinical trials for platinum-resistant ovarian cancer and other tumor types including pancreatic, melanoma, and colorectal cancers.
0 investors
0 investors
0 investors
Personalized Stem Cells develops regenerative medicine treatments using stem cells derived from adipose tissue, serving patients seeking cell therapies for conditions like osteoarthritis and other ailments in both humans and animals. The company operates from San Diego under FDA guidelines and offers stem cell banking and treatment services through its StemReady and StemPreserve programs.
0 investors
0 investors
0 investors
PetCure Oncology, founded in 2014, operates a network of veterinary cancer care centers offering stereotactic radiation therapy (SRS/SRT) and other cancer treatments for pets. It serves pet owners in the U.S. seeking advanced radiation oncology options for animals with cancer.
0 investors
0 investors
Petriage offers a telehealth platform for veterinary practices, providing tools to assess patient symptoms, connect with clients, and manage day-to-day operations. It serves veterinarians and their clients (pet owners) in the veterinary care industry.
0 investors
0 investors
Petros Pharmaceuticals is a bio-pharmaceutical company working to convert prescription drugs into over-the-counter self-care treatments, allowing consumers access without a physician visit or prescription. It operates in the emerging self-care pharmaceutical market.
0 investors
PetVivo is a veterinary biotech and biomedical device company that adapts human biotech and medical technology into products for the veterinary market. Its lead product, Spryng with OsteoCushion Technology, uses proprietary protein-based biomaterials to manage joint pain, lameness, and osteoarthritis in companion animals such as dogs and horses.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Phairify operates a platform connecting physicians to job opportunities and employers to physician candidates, using specialty-specific labor market data to facilitate transparent career matches. The platform serves physicians and healthcare employers seeking efficient, data-driven recruitment and placement.
0 investors
PharmaCyte is a biotechnology company developing Cell-in-a-Box, a live-cell encapsulation technology, to create cellular therapies for cancer, diabetes, and malignant ascites. The company encapsulates genetically engineered human cells to deliver localized drug activation or insulin production.
0 investors
PharmAdva makes the MedaCube, a smart automated pill dispenser that helps patients take prescribed medications correctly and lets caregivers and physicians monitor in-home medication adherence in real time. The device targets people who struggle to manage their medications, supporting independent living and reduced hospitalization.
0 investors
PharmaIN is a clinical-stage biopharmaceutical company developing peptide-based, subcutaneous self-injectable therapies through peptide engineering and drug delivery. Its pipeline targets advanced liver cirrhosis and cancer, including PHIN-214, a vasopressor therapy for decompensated cirrhosis in Phase 1 trials.
0 investors
Pharmatrophix is developing a small-molecule drug for Alzheimer's disease that acts upstream of amyloid, with Phase 2a trial imaging showing dose-dependent preservation of whole-brain connectivity. The company works in neurodegenerative disease drug development.
0 investors
0 investors
Pharmazz is a biopharmaceutical company developing and commercializing therapeutics for critical care and acute medicine, focused on Endothelin-B receptor agonists and resuscitative agents for conditions such as hypovolemic shock, ischemic stroke, and septic shock. Its lead products include Centhaquine (Lyfaquin) for hypovolemic shock and Tyvalzi for cerebral stroke, with operations in the U.S. and India.
0 investors